WAKE FOREST UNIVERSITY HEALTH SCIENCES
Initiating Preventive Care for Hyperlipidemia in the Emergency Department: The EMERALD Trial
Initiating Preventive Care for Hyperlipidemia in the Emergency Department: The EMERALD Trial is a funding opportunity from WAKE FOREST UNIVERSITY HEALTH SCIENCES, up to 156087, closing March 31, 2029.
Mar 31, 2029
(974d left)Overview
PROJECT SUMMARY/ABSTRACT Hyperlipidemia (HLD) is a major contributor to atherosclerotic cardiovascular disease (ASCVD), the leading cause of US mortality and morbidity. Nearly 30% of Emergency Department (ED) patients with chest pain have undiagnosed and/or unmanaged HLD, putting them at an increased risk of ASCVD.…